APO RESEARCH · REPORT
Sclerotherapy
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
Product & engineering
Understand the product.
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
Selected research
Industry Research
Sclerotherapy Industry Research Report 2026
Market perspective
Sclerotherapy is a procedure used to treat blood vessels or blood vessel malformations (vascular malformations) and also those of the lymphatic system. A medicine is injected into the vessels, which makes them shrink. It is used for children and young adults with vascular or lymphatic malformations. In adults, sclerotherapy is often used to treat spider veins, smaller varicose veins, and hemorrhoids.
In Eastern Europe, Sclerotherapy key players include BTG, Kreussler, LGM Pharma, Troikaa, Changan Tianyu group.
Russian is the largest market, with a share about 35%, followed by Ukraine and Poland, having a total share about 35 percent.
Read the full market overview
In terms of product, Detergents is the largest segment, with a share about 90%. And in terms of application, the largest application is Venous Disease, followed by Gastrointestinal Bleeding, Bronchopleural Fistula, Cystic Disease.
Report Scope
This report quantifies the global Sclerotherapy market in terms of revenue (US$ million) and, where applicable, service volume (K Pcs), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Sclerotherapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sclerotherapy Market by Company
BTG
Kreussler
LGM Pharma
Troikaa
Changan Tianyu group
Bioniche Pharma Group Ltd
Omega Pharmaceuticals
Angiodynamics
ENDO-FLEX
MTW ENDOSKOPIE
Cook Medical
Sclerotherapy Segment by Type
Detergents
Osmotic Agents
Chemical Irritants
Sclerotherapy Segment by Application
Venous Disease
Gastrointestinal Bleeding
Bronchopleural Fistula
Cystic Disease
Sclerotherapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sclerotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sclerotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sclerotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Sclerotherapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Detergents
- Osmotic Agents
- Chemical Irritants
Applications
- Venous Disease
- Gastrointestinal Bleeding
- Bronchopleural Fistula
- Cystic Disease
Companies covered
- BTG
- Kreussler
- LGM Pharma
- Troikaa
- Changan Tianyu group
- Bioniche Pharma Group Ltd
- Omega Pharmaceuticals
- Angiodynamics
- ENDO-FLEX
- MTW ENDOSKOPIE
- Cook Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Sclerotherapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Detergents
- 2.2.3 Osmotic Agents
- 2.2.4 Chemical Irritants
- 2.3 Sclerotherapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Venous Disease
- 2.3.3 Gastrointestinal Bleeding
- 2.3.4 Bronchopleural Fistula
- 2.3.5 Cystic Disease
- 2.4 Assumptions and Limitations
3 Sclerotherapy Breakdown Data by Type
- 3.1 Global Sclerotherapy Historic Market Size by Type (2021-2026)
- 3.2 Global Sclerotherapy Forecasted Market Size by Type (2027-2032)
4 Sclerotherapy Breakdown Data by Application
- 4.1 Global Sclerotherapy Historic Market Size by Application (2021-2026)
- 4.2 Global Sclerotherapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Sclerotherapy Market Perspective (2021-2032)
- 5.2 Global Sclerotherapy Growth Trends by Region
- 5.2.1 Global Sclerotherapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Sclerotherapy Historic Market Size by Region (2021-2026)
- 5.2.3 Sclerotherapy Forecasted Market Size by Region (2027-2032)
- 5.3 Sclerotherapy Market Dynamics
- 5.3.1 Sclerotherapy Industry Trends
- 5.3.2 Sclerotherapy Market Drivers
- 5.3.3 Sclerotherapy Market Challenges
- 5.3.4 Sclerotherapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Sclerotherapy Players by Revenue
- 6.1.1 Global Top Sclerotherapy Players by Revenue (2021-2026)
- 6.1.2 Global Sclerotherapy Revenue Market Share by Players (2021-2026)
- 6.2 Global Sclerotherapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Sclerotherapy Head Office and Area Served
- 6.4 Global Sclerotherapy Players, Product Type & Application
- 6.5 Global Sclerotherapy Manufacturers Established Date
- 6.6 Global Sclerotherapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Sclerotherapy Market Size (2021-2032)
- 7.2 North America Sclerotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Sclerotherapy Market Size by Country (2021-2026)
- 7.4 North America Sclerotherapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Sclerotherapy Market Size (2021-2032)
- 8.2 Europe Sclerotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Sclerotherapy Market Size by Country (2021-2026)
- 8.4 Europe Sclerotherapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Sclerotherapy Market Size (2021-2032)
- 9.2 Asia-Pacific Sclerotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Sclerotherapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Sclerotherapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Sclerotherapy Market Size (2021-2032)
- 10.2 South America Sclerotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Sclerotherapy Market Size by Country (2021-2026)
- 10.4 South America Sclerotherapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Sclerotherapy Market Size (2021-2032)
- 11.2 Middle East & Africa Sclerotherapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Sclerotherapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Sclerotherapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BTG
- 12.1.1 BTG Company Information
- 12.1.2 BTG Business Overview
- 12.1.3 BTG Revenue in Sclerotherapy Business (2021-2026)
- 12.1.4 BTG Sclerotherapy Product Portfolio
- 12.1.5 BTG Recent Developments
- 12.2 Kreussler
- 12.2.1 Kreussler Company Information
- 12.2.2 Kreussler Business Overview
- 12.2.3 Kreussler Revenue in Sclerotherapy Business (2021-2026)
- 12.2.4 Kreussler Sclerotherapy Product Portfolio
- 12.2.5 Kreussler Recent Developments
- 12.3 LGM Pharma
- 12.3.1 LGM Pharma Company Information
- 12.3.2 LGM Pharma Business Overview
- 12.3.3 LGM Pharma Revenue in Sclerotherapy Business (2021-2026)
- 12.3.4 LGM Pharma Sclerotherapy Product Portfolio
- 12.3.5 LGM Pharma Recent Developments
- 12.4 Troikaa
- 12.4.1 Troikaa Company Information
- 12.4.2 Troikaa Business Overview
- 12.4.3 Troikaa Revenue in Sclerotherapy Business (2021-2026)
- 12.4.4 Troikaa Sclerotherapy Product Portfolio
- 12.4.5 Troikaa Recent Developments
- 12.5 Changan Tianyu group
- 12.5.1 Changan Tianyu group Company Information
- 12.5.2 Changan Tianyu group Business Overview
- 12.5.3 Changan Tianyu group Revenue in Sclerotherapy Business (2021-2026)
- 12.5.4 Changan Tianyu group Sclerotherapy Product Portfolio
- 12.5.5 Changan Tianyu group Recent Developments
- 12.6 Bioniche Pharma Group Ltd
- 12.6.1 Bioniche Pharma Group Ltd Company Information
- 12.6.2 Bioniche Pharma Group Ltd Business Overview
- 12.6.3 Bioniche Pharma Group Ltd Revenue in Sclerotherapy Business (2021-2026)
- 12.6.4 Bioniche Pharma Group Ltd Sclerotherapy Product Portfolio
- 12.6.5 Bioniche Pharma Group Ltd Recent Developments
- 12.7 Omega Pharmaceuticals
- 12.7.1 Omega Pharmaceuticals Company Information
- 12.7.2 Omega Pharmaceuticals Business Overview
- 12.7.3 Omega Pharmaceuticals Revenue in Sclerotherapy Business (2021-2026)
- 12.7.4 Omega Pharmaceuticals Sclerotherapy Product Portfolio
- 12.7.5 Omega Pharmaceuticals Recent Developments
- 12.8 Angiodynamics
- 12.8.1 Angiodynamics Company Information
- 12.8.2 Angiodynamics Business Overview
- 12.8.3 Angiodynamics Revenue in Sclerotherapy Business (2021-2026)
- 12.8.4 Angiodynamics Sclerotherapy Product Portfolio
- 12.8.5 Angiodynamics Recent Developments
- 12.9 ENDO-FLEX
- 12.9.1 ENDO-FLEX Company Information
- 12.9.2 ENDO-FLEX Business Overview
- 12.9.3 ENDO-FLEX Revenue in Sclerotherapy Business (2021-2026)
- 12.9.4 ENDO-FLEX Sclerotherapy Product Portfolio
- 12.9.5 ENDO-FLEX Recent Developments
- 12.10 MTW ENDOSKOPIE
- 12.10.1 MTW ENDOSKOPIE Company Information
- 12.10.2 MTW ENDOSKOPIE Business Overview
- 12.10.3 MTW ENDOSKOPIE Revenue in Sclerotherapy Business (2021-2026)
- 12.10.4 MTW ENDOSKOPIE Sclerotherapy Product Portfolio
- 12.10.5 MTW ENDOSKOPIE Recent Developments
- 12.11 Cook Medical
- 12.11.1 Cook Medical Company Information
- 12.11.2 Cook Medical Business Overview
- 12.11.3 Cook Medical Revenue in Sclerotherapy Business (2021-2026)
- 12.11.4 Cook Medical Sclerotherapy Product Portfolio
- 12.11.5 Cook Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst